Edition:
United Kingdom

Novartis AG (NOVN.S)

NOVN.S on Virt-X Level 1

83.00CHF
4:29pm GMT
Change (% chg)

CHF-0.10 (-0.12%)
Prev Close
CHF83.10
Open
CHF83.20
Day's High
CHF83.35
Day's Low
CHF82.85
Volume
3,510,744
Avg. Vol
4,075,579
52-wk High
CHF85.40
52-wk Low
CHF69.50

Select another date:

Fri, Dec 8 2017

Photo

Roche, Novartis' Italian heads risk trial for alleged market rigging: sources

ROME The local heads of Swiss drugmakers Roche and Novartis risk facing trial in Italy for alleged market manipulation, judicial sources said on Friday.

Roche, Novartis' Italian heads risk trial for alleged market rigging- sources

ROME, Dec 8 The local heads of Swiss drugmakers Roche and Novartis risk facing trial in Italy for alleged market manipulation, judicial sources said on Friday.

BRIEF-Novartis Division Sandoz Says New Phase I Data Showing Proposed Biosimilar Pegfilgrastim Matches Reference Medicine‍​

* DIVISION SANDOZ SAYS NEW PHASE I DATA SHOWING PROPOSED BIOSIMILAR PEGFILGRASTIM MATCHES REFERENCE MEDICINE‍​ Source text for Eikon: Further company coverage: (Reporting by John Miller)

BRIEF-Advanced Accelerator Applications Announces Commencement Of Novartis Tender Offer

* ADVANCED ACCELERATOR APPLICATIONS ANNOUNCES COMMENCEMENT OF NOVARTIS TENDER OFFER

BRIEF-Novartis Says Premenopausal Women Taking Kisqali Benefited For Longer Time Until Health-Related QOL Deterioration

* NOVARTIS KISQALI IS FIRST AND ONLY CDK4/6 INHIBITOR TO SHOW SUPERIOR MEDIAN PFS COMPARED TO ORAL ENDOCRINE THERAPY AS FIRST-LINE TREATMENT IN A PROSPECTIVE, RANDOMIZED PHASE III TRIAL DEDICATED TO PREMENOPAUSAL WOMEN WITH HR+/HER2- ADVANCED BREAST CANCER

Australian watchdog takes GlaxoSmithKline, Novartis units to court

The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.

Australian watchdog takes GlaxoSmithKline, Novartis units to court

The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.

UPDATE 1-Australian watchdog takes GlaxoSmithKline, Novartis units to court

Dec 6 The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.

Australia competition watchdog takes GlaxoSmithKline, Novartis units to court

Dec 6 The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.

BRIEF-ACCC Institutes Proceedings Against GSK, Novartis

Dec 6 Australian Competition and Consumer Commission

Select another date: